Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial

OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER

David P. Rose, T. E. Davis · The Lancet · 1977 · 151 citations

Medicine, Gynecology, Oncology +10

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer

A R Bianco, Lucia Del Mastro, Ciro Gallo et al. · British Journal of Cancer · 1991 · 104 citations

Medicine, Oncology, Breast Oncology +6

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.

M A Richards, S.M. O'Reilly, Anthony Howell et al. · Journal of Clinical Oncology · 1990 · 101 citations · Full text

Medicine, Oncology, Pharmacology +16

Oestrogen receptor concentration in primary breast cancer and axillary node metastases

R. A. Hawkins, Robert B. Black, R. Steele et al. · Breast Cancer Research and Treatment · 1981 · 62 citations

Medicine, Endocrinology, Oncology +15

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer

EDC Anderson, APM Forrest, PA Levack et al. · British Journal of Cancer · 1989 · 61 citations · Full text

Medicine, Endocrinology, Oncology +13